Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wessels

Showing results (161-170 of 210) with videos related to

Pageof 21
Sort By:
Annals of Surgery|August 2, 2021
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched AnalysisLilly J H Brada, Lois A Daamen, Lisa G Magermans, et al.
Journal of Clinical Medicine|March 28, 2024
The Difficulty of Detecting Occult Metastases in Patients with Potentially Resectable Pancreatic Cancer: Development and External Validation of a Preoperative Prediction ModelMarieke Walma, Laura Maggino, F Jasmijn Smits, et al.
Journal of Neurology|July 23, 2025
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)W H Fung, M H J Wessels, E M E Coerver, et al.
Trials|June 20, 2024
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
Trials|July 5, 2024
Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
Journal of the Neurological Sciences|June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trialA A Toorop, M H J Wessels, L M Y Gelissen, et al.
BMC Cancer|April 22, 2018
Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study)H J F Brenkman, E C Gertsen, E Vegt, et al.
Annals of Surgical Oncology|March 25, 2024
Impact of <sup>18F</sup>FDG-PET/CT and Laparoscopy in Staging of Locally Advanced Gastric Cancer: A Cost Analysis in the Prospective Multicenter PLASTIC-StudyCas de Jongh, Miriam P van der Meulen, Emma C Gertsen, et al.
Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.
JAMA Surgery|October 27, 2021
18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC)Emma C Gertsen, Hylke J F Brenkman, Richard van Hillegersberg, et al.
Pageof 21

Showing results (161-170 of 210) with videos related to

Sort By:
Pageof 21
Annals of Surgery|August 2, 2021
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched AnalysisLilly J H Brada, Lois A Daamen, Lisa G Magermans, et al.
Journal of Clinical Medicine|March 28, 2024
The Difficulty of Detecting Occult Metastases in Patients with Potentially Resectable Pancreatic Cancer: Development and External Validation of a Preoperative Prediction ModelMarieke Walma, Laura Maggino, F Jasmijn Smits, et al.
Journal of Neurology|July 23, 2025
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)W H Fung, M H J Wessels, E M E Coerver, et al.
Trials|June 20, 2024
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
Trials|July 5, 2024
Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
Journal of the Neurological Sciences|June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trialA A Toorop, M H J Wessels, L M Y Gelissen, et al.
BMC Cancer|April 22, 2018
Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study)H J F Brenkman, E C Gertsen, E Vegt, et al.
Annals of Surgical Oncology|March 25, 2024
Impact of <sup>18F</sup>FDG-PET/CT and Laparoscopy in Staging of Locally Advanced Gastric Cancer: A Cost Analysis in the Prospective Multicenter PLASTIC-StudyCas de Jongh, Miriam P van der Meulen, Emma C Gertsen, et al.
Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.
JAMA Surgery|October 27, 2021
18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC)Emma C Gertsen, Hylke J F Brenkman, Richard van Hillegersberg, et al.
Pageof 21